Skip to main content
Home
About
Field Trip Health
Field Trip Discovery
Field Trip Digital
News
Press Releases
Events and Presentations
In the Media
Stock Information
CSE
OTC
Financials
SEDAR Filings
Governance
Board & Advisors
Management Team
Governance Documents
Whistleblower Portal
Contact Us
Investor FAQs
Information Request Form
Investor Email Alerts
Investor Contacts
Site Search
toggle main menu
In the Media
Home
About
Field Trip Health
Field Trip Discovery
Field Trip Digital
News
Press Releases
Events and Presentations
In the Media
Stock Information
CSE
OTC
Financials
SEDAR Filings
Governance
Board & Advisors
Management Team
Governance Documents
Whistleblower Portal
Contact Us
Investor FAQs
Information Request Form
Investor Email Alerts
Investor Contacts
Download item year list
2020
Date
Download
Description
November 9, 2020
Lucid News: New Program Brings Ketamine-Assisted Psychotherapy to Canadian Vets
(opens in new window)
October 7, 2020
Forbes: Psychedelic Therapy Company, Field Trip Health, Goes Public to Revolutionize Mental Health Treatments
(opens in new window)
October 6, 2020
Canadian Securities Exchange: Field Trip Health (CSE:FTRP) Opens the Stock Market | Canadian Securities Exchange
(opens in new window)
October 6, 2020
Benzinga: Field Trip Health Begins Trading On CSE
(opens in new window)
October 5, 2020
Psychedelic Stock Watch: Field Trip RTO Provides Exciting New Investing Option
(opens in new window)
October 2, 2020
Business Insider: Field Trip Health Ltd. Completes Reverse Takeover Transaction and Prepares for Listing on CSE
(opens in new window)
September 29, 2020
Psilocybin Alpha: Field Trip Announces Successful GLP Synthesis Results from Initial Preclinical Testing for FT-104, Its First Molecule in Development
(opens in new window)
September 29, 2020
Biotuesdays: Field Trip Completes GLP Synthesis of FT-104
(opens in new window)
Read More